Nano-enabled chemotheraphy for pancreatic cancer with improved…

Nano-enabled chemotheraphy for pancreatic cancer with improved safety and efficacy 

Authors Huan Meng and Xiangsheng Liu describe the custom-designing of a mesoporous silica nanoparticle (MSNP) platform to reduce the toxicity of irinotecan, a drug included in the four-drug regimen FOLFIRINOX, to treat pancreatic ductal adenocarcinoma (PDAC).

Read the related ACS Nano article at http://pubs.acs.org/doi/abs/10.1021/acsnano.5b07781

By: American Chemical Society.

Advertisements
Nano-enabled chemotheraphy for pancreatic cancer with improved…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s